
Hosted by Stephanie Dodier · EN

Confidence is not a personality trait you either have or don't.That is the conversation in this episode. Denise Wogan, a psychotherapist and Non-Diet Coaching Certification graduate, joins me four years after we worked together on the exact thing she was too scared to build: her own business.She has since done her first national TV interview, finished a psychotherapy degree, and started building a bricks and mortar clinic in Ireland. We talk about what actually changed.In this episode, you'll learn:Why confidence is created, not inheritedThe difference between fake confidence and the quiet, unshakable kindWhat self-trust actually feels like in the bodyWhy anxiety is a messenger, not an enemyHow eating became one woman's practice ground for trusting herself everywhere elseMentioned in the show:Denise Wogan on InstagramCoach Corner VaultNon-Diet Client Assessment ToolNon-Diet Coaching Certification WaitlistGroundwork Waitlist

Right as weight-inclusive medicine started gaining real ground, GLP-1 walked in and put BMI back at the center of the conversation.Dr. Lesley Williams has spent the last several years practicing weight-inclusive medicine inside a system built around this class of drugs.She is not on a side. She is in the room, every day, holding both a weight-neutral framework and a patient who wants a prescription.This conversation goes into what that actually looks like in practice.What you'll learnWhy the rise of GLP-1 felt like a step backwards for weight-inclusive medicine, even to a practitioner who believes in itThe shared decision-making framework she uses before ever discussing medicationWhy rapport has to outrank advocacy if a practitioner wants to stay in the room long termWhat she is already seeing: early adopters starting to come off the medicationWhere she believes weight-inclusive care is headed over the next five to ten yearsMentioned in the show:Beyond GLP-1 Expert Podcast Series: https://program.stephaniedodier.com/beyond-glp-1Dr. Lesley Williams website: http://www.lesleywilliamsmd.comDr. Lesley on Instagram: https://www.instagram.com/DrLesleyW/Coach Corner Vault: https://www.stephaniedodier.com/coach-corner/Non-Diet Client Assessment Tool: https://www.stephaniedodier.com/clientassessmentNon-Diet Coaching Certification Waitlist: https://www.stephaniedodier.com/non-diet-coaching-certification/Groundwork: https://www.stephaniedodier.com/groundwork

PCOS has a new name, and the internet has a lot of opinions about why.It's called PMOS now. Polyendocrine metabolic ovarian syndrome. Returning guest Julie Duffy Dillon joins me to break down what changed, what didn't, and what the research actually shows about GLP-1 medications and PCOS beyond weight loss.In this episode, you'll learn:Why PCOS was renamed PMOS after more than a decade of researchWhat the name change does and doesn't change about your careWhat the research shows about GLP-1s and PCOS insulin resistance, triglycerides, and androgensWhy insurance mostly covers the wrong dose, and who that leaves behindWhat to do when your provider starts talking about your weight againMentioned in the show:Beyond GLP-1 Expert Podcast Series: https://program.stephaniedodier.com/beyond-glp-1Julie's Substack: https://findyourfoodvoice.substack.com/Coach Corner Vault: https://www.stephaniedodier.com/coach-corner/Non-Diet Client Assessment Tool: https://www.stephaniedodier.com/clientassessmentNon-Diet Coaching Certification Waitlist: https://www.stephaniedodier.com/non-diet-coaching-certification/Groundwork: https://www.stephaniedodier.com/groundwork

We have a body autonomy problem and a body liberation problem, and they are not the same thing.Abbie Attwood joins me to talk about the conversation everyone is having badly right now. Celebrities, GLP-1s, and what it actually means to comment, or not comment, on someone else's body.In this episode you will learnWhy body autonomy and body liberation are not the same conversationWhat it means to critique a culture without critiquing a personWhy transparency about GLP-1 use does not erase the impact of the messageHow neurodivergence and chronic illness shape vulnerability to diet cultureWhat informed consent actually requires in the GLP-1 conversationMentioned in the show:Beyond GLP-1 Expert Podcast Series: https://program.stephaniedodier.com/beyond-glp-1Abbie's Substack: abbieattwoodwellness.substack.comAbbie on Instagram: instagram.com/abbieattwoodwellnessFull Plate Podcast (Abbie's podcast)Coach Corner Vault: https://www.stephaniedodier.com/coach-corner/Non-Diet Client Assessment Tool: https://www.stephaniedodier.com/clientassessmentNon-Diet Coaching Certification Waitlist: https://www.stephaniedodier.com/non-diet-coaching-certification/Groundwork Waitlist: https://www.stephaniedodier.com/groundwork

Food noise isn't a diagnosis. It's not a brain disorder. It might be the most cleverly marketed word for something that's been happening to diet-culture survivors for decades.Dr. Erin Knopf is triple-board certified in pediatrics, adult psychiatry, and child and adolescent psychiatry, and she specializes in eating disorders. In this episode of the Beyond GLP-1 series, she breaks down what food noise actually is in the brain, what GLP-1 medications do to it, and why silencing it with an injection is not the same as healing it.What you'll learn:The clinical definition of food noise — and why it's really hunger shaped by restriction and shameWhat GLP-1s actually do in the brain to quiet food preoccupation (and what that doesn't solve)Why there are only two published papers on food noise and no validated tool to measure itWhat 'body noise' is and how it shows up differently from food noiseWhy Dr. Knopf is deeply concerned about GLP-1 use in children and adolescentsMentioned in the show:Beyond GLP-1 Expert Podcast Series: https://program.stephaniedodier.com/beyond-glp-1Dr. Erin Knopf's Food Noise Reality Roadmap: https://foodnoiserealityroadmap.com/VERY | Virtual Eating Recovery: https://very.healthDr. Knopf on Instagram: @drerinknopfResearch: Food noise — concept and measurement (Nature, 2025): https://www.nature.com/articles/s41387-025-00382-xResearch: Food cue reactivity framework (PMC, 2023): https://pmc.ncbi.nlm.nih.gov/articles/PMC10674813/Coach Corner Vault: https://www.stephaniedodier.com/coach-corner/Non-Diet Client Assessment Tool: https://www.stephaniedodier.com/clientassessmentNon-Diet Coaching Certification Waitlist: https://www.stephaniedodier.com/non-diet-coaching-certification/Groundwork Waitlist: https://www.stephaniedodier.com/groundwork

Nobody screens you for disordered eating before prescribing a GLP-1. That is not an accident. It is a gap in the entire informed consent process, and it is the subject of this conversation.I talk with Dr. Michelle Tubman, an emergency physician, about what informed consent for GLP-1 medications should actually include and rarely does.In this episode you will learn:What Michelle sees in the emergency room after patients start GLP-1 medicationsWhy most people never connect their symptoms back to the medicationWhat the two-year Ozempic study actually found about weight regainWhy disordered eating screening is not required before a GLP-1 prescriptionWhat true informed consent would require, modeled on how oncologists handle chemotherapyMentioned in the show:Beyond GLP-1 Expert Podcast Series: https://program.stephaniedodier.com/beyond-glp-1Dr. Michelle Tubman Community: http://enough.wayzhealth.comDr. Michelle Tubman on Instagram: https://www.instagram.com/wayzahealth/Coach Corner Vault: https://www.stephaniedodier.com/coach-corner/Non-Diet Client Assessment Tool: https://www.stephaniedodier.com/clientassessmentNon-Diet Coaching Certification Waitlist: https://www.stephaniedodier.com/non-diet-coaching-certification/Groundwork Waitlist: https://www.stephaniedodier.com/groundwork

GLP-1 medications are changing how people experience food. What no one is telling you is they may also be changing how people experience everything else.In this episode I sit down with Olivia Palmer, chartered health psychologist and behavioral science specialist, to look at what these drugs are actually doing to the brain. Not the metabolic picture — the psychological one. We get into anhedonia, the flattening of the reward system, and what happens when the drive that was dampened for food also dampens motivation, connection, and the desire to pursue a meaningful life.Olivia also challenges one of the most common arguments circulating right now: that GLP-1 can serve as a behavioral kickstart that makes lasting health change easier. Her read of the behavioral science says otherwise.In this episode:What anhedonia is and how GLP-1 interacts with the brain's reward circuitryWhy the reward dampening effect is not selective to foodWhat behavioral science says about building health behaviors while biology is alteredThe gap in research — and why no one is asking the right questionsWhat to actually focus on for sustainable health behavior change, with or without GLP-1Mentioned in the show:Beyond GLP-1 Expert Podcast Series: https://program.stephaniedodier.com/beyond-glp-1Website-Olivia Palmer: http://oliviapalmer.co.ukOlivia Palmer Substack: https://substack.com/@oliviapalmerhealthInstagram - Olivia Palmer: https://www.instagram.com/oliviapalmerhealth/Coach Corner Vault: https://www.stephaniedodier.com/coach-corner/Non-Diet Client Assessment Tool: https://www.stephaniedodier.com/clientassessmentNon-Diet Coaching Certification Waitlist: https://www.stephaniedodier.com/non-diet-coaching-certification/Groundwork Waitlist: https://www.stephaniedodier.com/groundwork

The Ozempic era did not create weight stigma. It just showed us how shallow the acceptance always was.Dr. Angela Meadows is a social psychologist, weight stigma researcher, and founder of the International Weight Stigma Conference. She has spent her career studying how weight stigma operates at the individual, relational, and systemic level. In this conversation, she brings her research lens directly to the GLP-1 moment.This is the conversation mainstream health is not having.In this episode, you'll learn:Social identity theory — why the GLP-1 era exposed what body positivity was always missingWhat weight stigma actually is at the structural level, and why interpersonal niceness cannot fix a systemic problemThe public health data on GLP-1 that is buried in supplementary materials and not being readHow medicalized weight stigma is shifting — and why refusing GLP-1 is becoming its own form of clinical targetWhether it is possible to live in this culture and not internalize weight stigma, and what intentional protection requiresMentioned in the show:Beyond GLP-1 Expert Podcast Series: https://program.stephaniedodier.com/beyond-glp-1International Weight Stigma Conference: https://weightstigmaconference.com/GLP-1 Informed Consent Resource — Size Inclusive Medicine: https://sizeinclusivemedicine.org/wp-content/uploads/2023/11/MSSI-GLP1-Informed-Consent-1-1.pdfRelated episode — Beyond GLP-1 with Ragen Chastain: https://www.stephaniedodier.com/episodes/glp-1-science-research-weight-loss/Coach Corner Vault: https://www.stephaniedodier.com/coach-corner/Non-Diet Client Assessment Tool: https://www.stephaniedodier.com/clientassessmentNon-Diet Coaching Certification Waitlist: https://www.stephaniedodier.com/non-diet-coaching-certification/Groundwork Waitlist: https://www.stephaniedodier.com/groundwork

GLP-1 medications are being prescribed with no eating disorder screening and no monitoring. What could go wrong? According to eating disorder specialist and registered dietitian Marci Evans, quite a lot.Marci has spent her career at the intersection of body image and eating disorder care. In this conversation, she shares what she is actually seeing in her clinical practice and why it frightens her.What you will learn in this episode:Why weight loss does not reliably improve body image, even for people who want itHow GLP-1 medications can fuel and accelerate existing eating disorder behaviorsWhy there is almost no research on GLP-1 and body image, and what that tells usWhat the absence of screening and monitoring means for eating disorder riskHow weight-neutral practitioners can hold space for clients on GLP-1 without abandoning their clinical ethicsMentioned in the show:Beyond GLP-1 Expert Podcast Series: https://program.stephaniedodier.com/beyond-glp-1Marci Evans Newsletter on her website: https://marcird.com/Marci Evans on Instagram: https://www.instagram.com/marcird/Research — GLP-1 and body image: https://pubmed.ncbi.nlm.nih.gov/40267815/Research — GLP-1 and binge eating disorder: https://pmc.ncbi.nlm.nih.gov/articles/PMC11156433/Coach Corner Vault: https://www.stephaniedodier.com/coach-corner/Non-Diet Client Assessment Tool: https://www.stephaniedodier.com/clientassessmentNon-Diet Coaching Certification Waitlist: https://www.stephaniedodier.com/non-diet-coaching-certification/Groundwork Waitlist: https://www.stephaniedodier.com/groundwork

The science on GLP-1 drugs is not what the marketing says it is.Ragen Chastain has been studying weight science, weight stigma, and healthcare practice for over 20 years. In this episode, she gives us the clearest breakdown yet of what the research actually supports — as of May 2026 — and how to tell the difference between evidence and pharmaceutical strategy.This is part of the Beyond GLP-1 expert interview series on It's Beyond The Food.What you'll learn in this episode:Why GLP-1 drugs are solid for type 2 diabetes but how the weight loss dose is a fundamentally different useWhat the weight regain data actually shows — including what happens while people are still on the drugHow secondary use claims get built and why the cardiovascular trial results apply to far fewer people than the approval suggestsWhat the death data shows — and why Novo Nordisk was cited for under-reporting serious adverse eventsSpecific questions to ask your provider before starting a GLP-1 medication — and how to ask for weight-inclusive careMentioned in the show:Beyond GLP-1 Expert Podcast Series: https://program.stephaniedodier.com/beyond-glp-1Ragen Chastain's Weight and Healthcare Substack: https://weightandhealthcare.substack.com/Dances With Fat: https://danceswithfat.org/Ragen's speaking website — Sized for Success: https://www.sizedforsuccess.com/Dr. Rachel Fox's anti-obesity assemblage dissertation: https://www.rachelefox.com/research.htmlGLP-1 Informed Consent (Medical Students for Size Inclusivity, 2023): https://sizeinclusivemedicine.org/wp-content/uploads/2023/11/MSSI-GLP1-Informed-Consent-1-1.pdfLouise Adams on GLP-1 — listen to the earlier episode in the Beyond GLP-1 series: https://podcasts.apple.com/ph/podcast/468-beyond-glp-1-a-triumph-of-marketing-over/id1172102796?i=1000766587046